Sawai Pharmaceutical Co Ltd (4555.T)
17 Nov 2017
Get access to over 18 million research reports from over 1,700 sources.
For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.
Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.
Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:
- private equity
- third-party document and information retrieval
- and much, much more…
Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.
|79||2008||Chairman of the Board, Representative Director|
|60||2008||President, Representative Director|
|48||2017||Senior Managing Executive Officer, Director of Strategy Planning, Director|
|64||2013||Managing Executive Officer, Chief Director of Sales, President of Subsidiary, Director|
|63||2013||Managing Executive Officer, Chief Director of Administration, Deputy Chief Director of Sales, Director|
- REFILE-TABLE-Sawai Pharmaceutical- 6-MTH group results
- BRIEF-Sawai Pharmaceutical to sell 20 pct stake in SAWAI AMERICA for $211 mln
- BRIEF-Upsher-Smith says parent co to manufacture migraine medication in Japan With AstraZeneca
- REFILE-TABLE-Sawai Pharmaceutical-Q1 group results
- BRIEF- Sawai Pharmaceutical completes acquisition of Upsher-Smith Laboratories for $1.05 bln